Palatin Technologies Inc. (PTN) was a big mover last session, with shares rising nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading way above the past one month’s volatile price range of $1.00 to $1.15.
This biopharmaceutical company has witnessed three positive estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies strong trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s sharp climb can turn into more strength down the road.
Palatin currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may consider better-ranked stocks like Alexion Pharmaceuticals, Inc. (ALXN), Gilead Sciences Inc. (GILD) and Actelion Ltd. (ALIOF). While ALXN and GILD sport a Zacks Rank #1 (Strong Buy), ALIOF bears a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PALATIN TECH INC (PTN): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
GILEAD SCIENCES INC (GILD): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
Zacks Investment Research